{"count": 1, "results": [{"_id": "25912112", "pmid": 25912112, "title": "Simvastatin-ezetimibe combination therapy is associated with a lower rate of major adverse cardiac events in type 2 diabetics than high potency statins alone: A population-based dynamic cohort study.", "journal": "Int J Cardiol", "authors": ["Chang SH", "Wu LS", "Lee CH", "Kuo CT", "Liu JR", "Wen MS", "Chen WJ", "See LC", "Yeh YH"], "date": "2015-01-01T00:00:00Z", "doi": "10.1016/j.ijcard.2015.04.121", "meta_date_publication": "2015", "meta_volume": "190", "meta_issue": "", "meta_pages": "20-5", "score": 50081.33, "text_hl": "@<m>CHEMICAL_Ezetimibe_Simvastatin_Drug_Combination</m> @CHEMICAL_MESH:D000069499 @@@Simvastatin-ezetimibe@@@ combination therapy is associated with a lower rate of @<m>DISEASE_Epilepsy_Tonic_Clonic</m> @DISEASE_MESH:D004830 @@@major@@@ adverse @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiac events@@@ in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetics@@@ than high potency statins alone: A population-based dynamic cohort study.", "citations": {"NLM": "Chang SH, Wu LS, Lee CH, Kuo CT, Liu JR, Wen MS, Chen WJ, See LC, Yeh YH. Simvastatin-ezetimibe combination therapy is associated with a lower rate of major adverse cardiac events in type 2 diabetics than high potency statins alone: A population-based dynamic cohort study. Int J Cardiol. 2015;190():20-5. PMID: 25912112", "BibTeX": "@article{25912112, title={Simvastatin-ezetimibe combination therapy is associated with a lower rate of major adverse cardiac events in type 2 diabetics than high potency statins alone: A population-based dynamic cohort study.}, author={Chang SH and Wu LS and Lee CH and Kuo CT and Liu JR and Wen MS and Chen WJ and See LC and Yeh YH}, journal={Int J Cardiol}, volume={190}, pages={20-5}}"}}]}